Pathology

Thomas H. Haugen, MD, PhD

Portrait

Director, Pathology and Laboratory Service, Veterans Administration Medical Center
Associate Professor of Pathology  - Clinical Pathology

Contact Information

Primary Office: 113 Veterans Administration Medical Center
601 Highway 6 West
Iowa City, IA 52246
Primary Office Phone: 319-338-0581

Email: thomas-haugen@uiowa.edu
Web: Dr. Haugen's Research Laboratory

Education

BA, Biochemistry, University of California, Berkeley, CA
PhD, Biochemistry, University of California, Davis, CA
MD, University of Iowa, Iowa City, IA

Residency, Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA
Fellowship, Microbiology, University of Iowa Hospitals and Clinics, Iowa City, IA

Licensure and Certifications

Clinical Pathology American Board of Pathology
Federal Licensing Examination (FLEX) Federation of State Medical Boards

Education/Training Program Affiliations

Department of Pathology Graduate Program

Research Summary

Regulation of human papillomavirus gene expression by viral and cellular factors.

Center, Program and Institute Affiliations

Holden Comprehensive Cancer Center

Selected Publications

Show All

Lace M, Anson J, Haugen T, Dierdorf J, Turek L.  Interferon treatment of human keratinocytes harboring extrachromosomal, persistent HPV-16 plasmid genomes induces de novo viral integration.  Carcinogenesis.  2014 November 21. 
[PubMed]

Dee F, Haugen T, Kreiter C.  New web-based applications for mechanistic case diagramming.  Med Educ Online;  2014. 

Lace M, Turek L, Anson J, Haugen T.  Analyzing the Human Papillomavirus (HPV) Life Cycle in Primary Keratinocytes with a Quantitative Colony-Forming Assay.  Curr Protoc Microbiol.  2014 May 1. 
[PubMed]

Lace M, Ushikai M, Yamakawa Y, Anson J, Ishiji T, Turek L, Haugen T.  The truncated C-terminal E2 (E2-TR) protein of bovine papillomavirus (BPV) type-1 is a transactivator that modulates transcription in vivo and in vitro in a manner distinct from the E2-TA and E8^E2 gene products.  Virology.  2012 August. 429(2):99-111.
[PubMed]

Smith E, Rubenstein L, Haugen T, Pawlita M, Turek L.  Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease.  Journal of Oncology.  2012. 2012:571862.
[PubMed]

Lace M, Anson J, Klussmann J, Wang D, Smith E, Haugen T, Turek L.  Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers.  Journal of virology.  2011 February. 85(4):1645-54.
[PubMed]

Kreiter C, Haugen T, Leaven T, Goerdt C, Rosenthal N, McGaghie W, Dee F.  A report on the piloting of a novel computer-based medical case simulation for teaching and formative assessment of diagnostic laboratory testing.  Medical education online.  2011. 16.
[PubMed]

Rubenstein L, Smith E, Pawlita M, Haugen T, Hamšíková E, Turek L.  Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study.  Infectious agents and cancer.  2011. 6(1):9.
[PubMed]

Smith E, Rubenstein L, Haugen T, Hamsikova E, Turek L.  Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers.  Cancer causes & control: CCC.  2010 September. 21(9):1369-78.
[PubMed]

Smith E, Pawlita M, Rubenstein L, Haugen T, Hamsikova E, Turek L.  Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer.  International journal of cancer.  2010 July. 127(1):111-7.
[PubMed]

Date Last Modified: 06/07/2014 - 21:56:23